QPS excels in trials involving highly specific patient populations, rare diseases, and demanding protocols. The QPS experience combines flexibility, agility and speed, with proven procedures, networks and a scientific approach to support success at every milestone.
As part of a full service CRO, the QPS Clinical Research Division supports research in every clinical stage. QPS has extensive clinical experience across multiple Therapeutic Areas, including: CNS, Dermatology, Diabetes, Gynecology, Infectious Disease, Inflammation, Metabolic Disorders, Neurology, Pain,
Respiratory, Urology, Vaccines, and Rare Diseases.
Trials enrolling special patient populations like the elderly, children, pregnant women, breastfeeding women and others, require a higher level of experience and attention to adequately address the associated risks and challenges. However, there might also be benefits for these populations, like access to newer treatments and general medical care. It is the task of the CRO to efficiently leverage these benefits in order to ensure an optimum performance of the study.
Furthermore, certain patient populations require specific doses and/or treatment schedules. Depending on the specific patient population, the schedules of families, caregivers or other parties involved need to be considered appropriately. Otherwise, patient recruitment and/or patient retention may become a significant challenge.
Customized clinical trial advertising, using social media and other web-based tools is usually appropriate to efficiently target special patient populations. Digitally savy recruitment experts and a reasonable budget are essential prerequisites to effectively maximize these channels.